Bashi Ratterree
Oregon Health & Science University(US)
Publications by Year
Research Areas
CAR-T cell therapy research, T-cell and B-cell Immunology, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer(2005)288 cited
- → Phase II Study of G3139, a Bcl-2 Antisense Oligonucleotide, in Combination With Dexamethasone and Thalidomide in Relapsed Multiple Myeloma Patients(2005)96 cited
- → Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells(2003)39 cited
- → Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma(2004)21 cited
- → Phase II Trial of Oblimersen Sodium (G3139), Dexamethasone (Dex) and Thalidomide (Thal) in Relapsed Multiple Myeloma Patients (Pts).(2004)9 cited
- → A Phase I/II Study of Vorinostat (SAHA), Cladribine (2-CdA), and Rituximab Shows Significant Activity in Previously Untreated Mantle Cell Lymphoma(2011)4 cited
- → Adoptive transfer of ex vivo costimulated autologous T-cells after autotransplantation for myeloma (MM)accelerates post-transplant T-cell recovery(2004)3 cited
- → Adoptive Transfer of Ex Vivo Costimulated Autologous T-Cells in Conjunction with Pneumococcal Conjugate Vaccine Immunizations Accelerates Post-Transplant T-Cell Recovery after Autotransplantation for Myeloma: Results of a Randomized Study.(2004)3 cited
- → Real World Experience of a Single-Center Tumor Infiltrating Lymphocyte (TIL) Melanoma Therapy Program: primary referral to TIL infusion (Brain to Vein)(2025)1 cited
- → Activity of vorinostat (SAHA), cladribine (2-CdA), and rituximab in previously untreated mantle cell lymphoma: A phase I/II study.(2011)1 cited